Arcturus Therapeutics Holdings Inc ARCT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:11 PM EDT
13.05UNCH (UNCH)
Volume
20,959
Close
13.05quote price arrow down-0.57 (-4.18%)
Volume
383,037
52 week range
11.70 - 51.58
Loading...
  • Open13.42
  • Day High14.56
  • Day Low13.02
  • Prev Close13.62
  • 52 Week High51.58
  • 52 Week High Date09/27/21
  • 52 Week Low11.70
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap346.87M
  • Shares Out26.58M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.69
  • YTD % Change-64.74

KEY STATS

  • Open13.42
  • Day High14.56
  • Day Low13.02
  • Prev Close13.62
  • 52 Week High51.58
  • 52 Week High Date09/27/21
  • 52 Week Low11.70
  • 52 Week Low Date06/16/22
  • Market Cap346.87M
  • Shares Out26.58M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.69
  • YTD % Change-64.74

RATIOS/PROFITABILITY

  • EPS (TTM)-6.28
  • P/E (TTM)-2.08
  • Fwd P/E (NTM)-2.33
  • EBITDA (TTM)-162.70M
  • ROE (TTM)-69.48%
  • Revenue (TTM)40.57M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-407.91%
  • Debt To Equity (MRQ)36.77%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arcturus Therapeutics Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Arcturus Therapeutics Holdings Inc. is a late-stage global clinical messenger ribonucleic acid (mRNA) medicines company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its mRNA platform, the Company's lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology...
Peter Farrell Ph.D.
Independent Chairman of the Board
Joseph Payne
President, Chief Executive Officer, Director
Padmanabh Chivukula
Chief Operating Officer, Chief Scientific Officer
Andrew Sassine
Chief Financial Officer, Director
Address
10628 Science Center Dr Ste 250
San Diego, CA
92121-1132
United States